Three antidepressants may work better than fluoxetine, widely known by the brand name Prozac, at helping people with depression get better and stay well over time, a new study suggests.
The research, published in The Lancet Psychiatry, compared 20 antidepressants to determine how well they eased depression symptoms and helped prevent them from returning over time.
Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands.
CERTAIN SLEEP HABITS COULD OFFER CLUES TO HIDDEN TYPE OF DEPRESSION, SCIENTISTS SAY
They found that escitalopram, sold under the brand name Lexapro; duloxetine, sold as Cymbalta; and agomelatine performed better over the long term than fluoxetine, which researchers used as the main comparison drug.
Eli Lilly told Fox News Digital that it discontinued manufacturing Prozac in 2024. The company noted that fluoxetine remains available in many FDA-approved generic medicines and that neither the study nor the university’s news release specifically referred to Prozac or any Lilly product.
The findings suggest that antidepressants can continue helping people after their symptoms improve, although some medications appeared to work better than others at keeping patients well.
Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three medications have different benefits and drawbacks.
CLICK HERE FOR MORE HEALTH STORIES
"Escitalopram is already widely used," he said in the release. "Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less well-known and is prescribed less frequently as a first-line treatment."
Escitalopram belongs to a common group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs. These medications are often recommended as a first option for treating depression, according to the release.
Among the SSRIs included in the study, escitalopram appeared to work best at helping patients stay well over time.
Eric Ruhé, a professor of difficult-to-treat depression at Radboud University Medical Center, said the findings could eventually influence how doctors choose antidepressants. Still, the researchers stressed that this does not mean everyone with depression should take escitalopram.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
"As a prescriber, you consider the balance between a medication's benefits and side effects," Ruhé said in the release. "That balance differs from person to person."
Dr. Carole Lieberman, a board-certified psychiatrist based in Beverly Hills, California, who was not involved in the study, urged caution when interpreting the findings.
She noted that agomelatine is not approved in the U.S.
"The best way to treat someone with depression is not always with antidepressants, and certainly not with antidepressants alone," Lieberman told Fox News Digital.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Psychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication along with therapy.
There were some limitations to the study, the researchers acknowledged.
Rather than enrolling a new group of patients and following them over time, the researchers combined results from 115 previous clinical trials to compare how the medications performed.
The findings also cannot predict which antidepressant will work best for a specific person. The researchers stressed that doctors and patients should consider both the potential benefits and side effects when choosing a medication.
People with questions about their antidepressants should speak with their doctor before making any medication changes, according to the release.
Fox News Digital reached out to the researchers and additional drug manufacturers for comment.